Active Ingredient: DAROLUTAMIDE
Proprietary Name: NUBEQA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N212099
Product Number: 001
Approval Date: Jul 30, 2019
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
